Cargando…
Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency
BACKGROUND: Due to the recent European legislations posing a ban of animal tests for safety assessment within the cosmetic industry, development of in vitro alternatives for assessment of skin sensitization is highly prioritized. To date, proposed in vitro assays are mainly based on single biomarker...
Autores principales: | Albrekt, Ann-Sofie, Johansson, Henrik, Börje, Anna, Borrebaeck, Carl, Lindstedt, Malin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932014/ https://www.ncbi.nlm.nih.gov/pubmed/24517095 http://dx.doi.org/10.1186/2050-6511-15-5 |
Ejemplares similares
-
A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests
por: Johansson, Henrik, et al.
Publicado: (2011) -
Prediction of Chemical Respiratory Sensitizers Using GARD, a Novel In Vitro Assay Based on a Genomic Biomarker Signature
por: Forreryd, Andy, et al.
Publicado: (2015) -
Evaluation of high throughput gene expression platforms using a genomic biomarker signature for prediction of skin sensitization
por: Forreryd, Andy, et al.
Publicado: (2014) -
Different In Vitro-Generated MUTZ-3-Derived Dendritic Cell Types Secrete Dexosomes with Distinct Phenotypes and Antigen Presentation Potencies
por: Sakamoto, Takuya, et al.
Publicado: (2022) -
Titanium salts tested in reconstructed human skin with integrated MUTZ‐3‐derived Langerhans cells show an irritant rather than a sensitizing potential
por: Rodrigues Neves, Charlotte T., et al.
Publicado: (2020)